Enzymes

Subscribe to Selected New Research on Enzymes

25587 relevant articles (491 outcomes, 2241 trials/studies) found for this Bio-Agent

Description: Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.

Also Known As:

Biocatalysts

Relationship Network

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1

Enzymes: 25587

Oxidoreductases: 7118

DNA Repair Enzymes: 149

Catalytic DNA: 74

Penicillin-Binding Proteins: 52

Immobilized Enzymes: 20

Lyases: 17

Isomerases: 16

Holoenzymes: 13

DNA Restriction-Modification Enzymes: 7

Multienzyme Complexes: 7

Arabidopsis epithiospecifier protein

hepabionta compositum

hydroxymethylbutenyl 4-diphosphate synthase

Irgazyme 100

L 989

Lactococcus lactis LctM protein

lecithovitellase

magnesium dechelatase

onoton

osto-zyme

pyruvate formate-lyase activating enzyme

sheath degrading enzyme

streptococcus bacteriophage lysin

Thauera aromatica BssD protein

vitopine synthase

Experts

1.	Suzuki, Takashi: 6 articles (03/2008 - 03/2005)
2.	Sasano, Hironobu: 6 articles (03/2008 - 03/2005)
3.	Birkner, Ewa: 5 articles (08/2008 - 01/2003)
4.	Moriya, Takuya: 5 articles (03/2008 - 03/2005)
5.	Barton, J R: 5 articles (03/2002 - 08/2000)
6.	Gibson, Gary E: 4 articles (04/2008 - 01/2004)
7.	Gelb, Michael H: 4 articles (04/2008 - 03/2004)
8.	Scott, C Ronald: 4 articles (04/2008 - 03/2004)
9.	Turecek, Frantisek: 4 articles (04/2008 - 03/2004)
10.	Vaziri, Nosratola D: 4 articles (07/2006 - 02/2004)

Related Diseases

1.	Neoplasms (Cancer) 03/28/2006 - "At his most recent visit in May 2005, the patient was asymptomatic, liver enzymes were normal and the tumor was in remission on ultrasound." 03/08/2006 - "Eventually, this may help to truly individualize the dosing of this (and other) anti-cancer agent(s), using a personal genetic profile of the most relevant enzymes for every patient." 01/01/1999 - "A knowledge of the complete sequence of events, from the gene to the outcome, would be helpful in unravelling the implications and possible preventive and treatment strategies to be employed in cases where clear associations between carcinogen-metabolizing enzymes and cancer susceptibility have been uncovered." 11/01/2009 - "Gastric human neoplasms showed significant changes in antioxidant enzymes, that represent the first line in antioxidant protection against radical attack. " 01/01/2002 - "Our improved understanding of these enzymes will have significant benefits in such diverse areas as drug design and development, cancer susceptibility, reproduction and development." Order ALL the reference details at left...
2.	Infection 06/01/2000 - "CONCLUSIONS: These results establish that human intestinal epithelium expresses and apically secretes SLPI, a molecule that may significantly contribute to the protection against attack from inflammatory cells and digestive enzymes, as well as against microbial infection." 06/01/1994 - "Infection of human endothelial cells by Rickettsia rickettsii causes a significant reduction in the levels of key enzymes involved in protection against oxidative injury." 01/01/2008 - "The present study concerned the phosphorylation of Arabidopsis eIF2alpha (AteIF2alpha) by the Arabidopsis homologue of GCN2, AtGCN2, and the role of AtGCN2 in regulating genes encoding enzymes of amino acid biosynthesis and responding to virus infection. " 01/01/2008 - "This study investigated the effects of Photorhabdus temperata infection on the activities of digestive enzymes of the sugarcane stalk borer Diatraea saccharalis. " 02/01/2006 - "Verification of enzyme function by biochemical investigations and validation of gene essentiality by knockout studies may reveal these enzymes to be rational drug targets for treatment of persistent microbial infections in mechanism-based drug discovery processes." Order ALL the reference details at left...
3.	Pancreatitis 03/01/1991 - "The role of various drugs to suppress pancreatic secretion and inhibit pancreatic enzymes, although shown to be consistently effective in experimental pancreatitis, has not been established by controlled clinical trials in humans. " 06/01/1996 - "BACKGROUND: Diagnosis of acute pancreatitis (AP) has been improved in the past 15 yr as new methods for the determination of specific pancreatic enzymes have been developed. " 01/01/2002 - "The findings suggest the possible roles of HSP60 and (or) HSP72 (but not that of the antioxidant enzymes) in the protection against CCK- and TC-induced acute pancreatitis. " 03/01/1995 - "Determination of serum pancreatic enzymes remains the gold standard for the diagnosis of acute pancreatitis. " 09/01/1964 - "[HAVE ANTI-ENZYMES REALLY IMPROVED THE PROGNOSIS OF NECROTICO-HEMORRHAGIC ACUTE PANCREATITIS?]" Order ALL the reference details at left...
4.	Ischemia 09/01/1998 - "After 90 minutes of ischemia, low doses of FK and TAK significantly improved hepatic microcirculation and reduced portal pressure following reperfusion in group III compared with group I. Leakage of hepatic enzymes was prevented and tissue injury score was significantly lower in group III. In group VI, early protection was obtained to some extent; however, blood pressure was reduced significantly following reperfusion compared with group I. In contrast, hepatocellular function deteriorated and the tissue injury score was higher in group II animals. " 03/01/2006 - "Antioxidant enzymes in ringed seal tissues: potential protection against dive-associated ischemia/reperfusion." 01/01/2009 - "This paper describes our study on extracting these enzymes from red blood cells and analyzing the amount of enzymes needed for adequate protection from ischemia-reperfusion." 01/01/2006 - "The results of the study suggest that further studies on extracellular enzymes are required for the assessment of antioxidant system in the conditions of ischemia/reperfusion." 04/01/2005 - "OBJECTIVE: To study the change regulation of enzymes in serum for the diagnosis and treatment of acute mesenteric ischemia by earlier period. " Order ALL the reference details at left...
5.	Body Weight (Weight, Body) 04/01/1985 - "However, the various biochemical and morphological expressions of these changes and the discrepancy between unchanged liver weight, liver:body weight ratio, liver enzymes, and the improved hepatic fat content suggest multifactorial mechanisms for TPN-related liver damage." 11/01/2005 - "The present study was performed to investigate the effects of three Zn levels, including Zn adequate (35.94 mg/kg, as a control), Zn deficiency (3.15 mg/kg), and Zn overload (347.50 mg/kg) in growing male rats for 6 wk. This allowed for evaluation of the effects that these Zn levels might have on body weight, organ weight, enzymes activities, and tissues concentrations of Zn and Cu. " 12/01/1991 - "Study participants having elevated enzymes had higher ideal body weight (IBW) than the group with normal values at screening (162 +/- 10 percent IBW, 152 +/- 11 percent IBW respectively), and at week 8 (152 +/- 3 percent IBW, 146 +/- 2 percent respectively) (P less than 0.05). " 05/01/1991 - "In the present study, we examined effects of 2,5,2',5'-TCB and its major metabolite 3-hydroxy-2,5,2',5'-TCB on body weight gain, organ weights and activities of hepatic enzymes in rats and assessed acute toxicity of these compounds. " 01/01/1987 - "In the efficacy studies the activities of several serum enzymes and the plasma concentrations of Fe, Zn, and Cu were measured, but it appeared, that these biochemical parameters were no better than the clinical parameters body temperature and body weight. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Superoxide Dismutase
2.	Glutathione (Reduced Glutathione)
3.	Glutathione Peroxidase
4.	Oxygen
5.	Catalase
6.	DNA (Deoxyribonucleic Acid)
7.	Glucose (Dextrose)
8.	Fluorouracil (Carac)
9.	Messenger RNA (mRNA)
10.	Antioxidants

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Plasma Exchange
3.	Heterologous Transplantation (Xenotransplantation)
4.	Aftercare (After-Treatment)
5.	Oral Administration

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>